Investing Port

P/E	877.75
P/S	30.01
P/BV	24.8
EV/EBITDA	479.98
EBITDA	0.0098
Цена ао	105.33

		Недооценка Название Значение Оценка P/S 30.01 1 P/BV 24.8 1 P/E 877.75 1 EV/EBITDA 479.98 1	Эффективность Название Значение Оценка ROA, % 1.8 1 ROE, % 3.31 1
	Дивиденды Название Значение Оценка Div yield, % 0 DSI 0 0	Долг Название Значение Оценка Долг/EBITDA 0	Импульс роста Название Значение Оценка Рост прибыли, % 0 0 Рост цены акции, % 0 0 Рост дивидендов, % 0 0

Institutions	Объем	Доля, %
Sumitomo Mitsui DS Asset Management Company, Limited	337100	0.21
T. Rowe Price Associates, Inc.	20448000	12.74
Asset Management One Co., Ltd.	518700	0.32
Aberdeen Standard Investments Limited	53400	0.03
FIL Fund Management Limited	112615	0.07
FIL Life Insurance Limited	126434	0.08
T. Rowe Price	14521600	9.05
Schroder Investment Management(Japan)Ltd	109700	0.07
Aberdeen	180500	0.11
Nikko Asset Management Co Ltd	2052800	1.28
RMB Capital Management, LLC	140600	0.09
FIL Investments (Japan) Limited	1652000	1.03
Aberdeen Asset Mgmt	94800	0.06
Investors Group Inc	289000	0.18
Aberdeen Asset Managers Ltd	94800	0.06
Harding Loevner LP	533115	0.33
Evli Fund Management Company Oy	25600	0.02
Standard Life Assurance Company	2570000	1.6
BlackRock Fund Advisors	3900197	2.43
Aberdeen Standard Investments Luxembourg S.A.	553143	0.34
Aberdeen Standard Investments (Asia) Limited	4900	0
Harding Loevner L.P.	21255	0.01
BlackRock Advisors (UK) Limited	698456	0.43
Aberdeen Standard Investments Inc.	2104	0
SunAmerica Asset Management, LLC	170200	0.11
Ivy Investment Management Company	148500	0.09

ETF	Доля, %	Доходность за год, %
VictoryShares US Discovery Enhanced Volatility Weighted ETF	0.35	64.12
VictoryShares US Small Cap Volatility Weighted ETF	0.35	41.40
SPDR S&P Health Care Equipment ETF	1.74	47.12
Invesco S&P MidCap 400® Pure Growth ETF	2.45	52.98
ROBO Global Healthcare Technology and Innovation ETF	1.78	78.90

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells its products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Lake Forest, California.